0.888 0 (0%) 01-01 01:00 |
|
Open: | 0.878 |
High: | 0.890 |
Low: | 0.876 |
Pre. close: | 0.888 |
Volume: | 761,376 |
Avg. volume: | 402,314 |
MA (50): | 0.815 |
MA (200): | 1.381 |
Year high: | 2.775 |
Year low: | 0.700 |
Market cap: | 0(M) |
EPS: | -0.636 |
PE ratio: | -1.396 |
SELL | BUY |
HeikinAshi: | |
Kaufmans AMA: | |
Chandelier (20): | |
MA (5): | |
MA (50): | |
MACD (26,12,9): | |
Slow KDJ (14,3): | |
RSI (14): | |
CCI (20): |
Thu, 10 Oct 2024
Global Antiemetics Drugs Market to Exhibit Growth at a CAGR of ~6% by 2030 | DelveInsight - GlobeNewswire
Thu, 03 Oct 2024
Anti-Hypertensive Drugs Global Market Innovations Investigated by Size, Share, Growth, Trends, Forecast to ... - WhaTech
Thu, 31 Mar 2022
Acacia is valued at €94.7m in sale to Eagle Pharmaceuticals - Cambridge Independent
Wed, 30 Mar 2022
Eagle Pharmaceuticals and Acacia Pharma Transaction - William Blair
Mon, 28 Mar 2022
Eagle Pharma Adds Hospital-Based Products With €95M Acacia Pharma Deal - Yahoo Finance
Mon, 28 Mar 2022
Eagle Announces Acquisition of Acacia in Strategic Good Fit - BioSpace
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.